Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 6/2015

01-11-2015 | Original Article

Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study

Authors: Michel Hochuli, Emanuel Christ, Fabian Meienberg, Roger Lehmann, Jan Krützfeldt, Matthias R. Baumgartner

Published in: Journal of Inherited Metabolic Disease | Issue 6/2015

Login to get access

Abstract

Background

Traditional approaches for nighttime glycemic control in glycogen storage disease type I (GSDI) include continuous tube feeding, or ingestion of uncooked corn starch (CS) at bedtime. A modified corn starch (MCS) has been shown to prolong euglycemia in some patients. The aim of this study was to evaluate whether stable nighttime glucose control can be achieved with other types of slowly digested carbohydrates in adult GSDI patients.

Methods

In this cross-over study, nocturnal glucose control and fasting times were assessed with three different nocturnal nutrition regimens in five patients, using continuous glucose monitoring (CGMS) in an outpatient everyday life setting. For each patient, continuous glucose profiles were measured after ingestion of (1) CS, (2) MCS or (3) a pasta meal at bedtime, during 5 to 6 consecutive nights for each regimen.

Results

Stable nocturnal glucose control was achieved for all patients with a pasta meal, with a mean duration of glycemia >3.5 mmol/l of 7.6 h (range 5.7-10.8), and >4 mmol/l of 7 h (5.2-9.2), similar to CS and MCS. Fasting glucose before breakfast on workdays (after 7.1 ± 0.8 h) was not significantly different between the three interventions (CS 4.1 ± 0.5 mmol/l, MCS 4.6 ± 0.7 mmol/l, pasta 4.3 ± 0.9 mmol/l). During prolonged fasting on weekends, longer duration of normoglycemia was achieved with CS or MCS than with pasta.

Conclusion

Consumption of cooked pasta is a suitable and more palatable alternative to uncooked corn starch to achieve nighttime glucose control in adult patients with GSDI.
Literature
go back to reference Aravind N, Sissons M, Fellows CM, Blazek J, Gilbert EP (2013) Optimisation of resistant starch II and III levels in durum wheat pasta to reduce in vitro digestibility while maintaining processing and sensory characteristics. Food Chem 136:1100–1109CrossRefPubMed Aravind N, Sissons M, Fellows CM, Blazek J, Gilbert EP (2013) Optimisation of resistant starch II and III levels in durum wheat pasta to reduce in vitro digestibility while maintaining processing and sensory characteristics. Food Chem 136:1100–1109CrossRefPubMed
go back to reference Bhattacharya K (2011) Dietary dilemmas in the management of glycogen storage disease type I. J Inherit Metab Dis 34:621–629CrossRefPubMed Bhattacharya K (2011) Dietary dilemmas in the management of glycogen storage disease type I. J Inherit Metab Dis 34:621–629CrossRefPubMed
go back to reference Bhattacharya K, Orton RC, Qi X et al (2007) A novel starch for the treatment of glycogen storage diseases. J Inherit Metab Dis 30:350–357CrossRefPubMed Bhattacharya K, Orton RC, Qi X et al (2007) A novel starch for the treatment of glycogen storage diseases. J Inherit Metab Dis 30:350–357CrossRefPubMed
go back to reference Bjorck I, Granfeldt Y, Liljeberg H, Tovar J, Asp NG (1994) Food properties affecting the digestion and absorption of carbohydrates. Am J Clin Nutr 59:699s–705sPubMed Bjorck I, Granfeldt Y, Liljeberg H, Tovar J, Asp NG (1994) Food properties affecting the digestion and absorption of carbohydrates. Am J Clin Nutr 59:699s–705sPubMed
go back to reference Chen Y-T, Kishnani PS, Koeberl D (2013) Glycogen storage diseases. In: Beaudet AL, Vogelstein B, Kinzler KW et al (eds) The online metabolic and molecular bases of inherited disease New York. The McGraw-Hill Companies, Inc., NY Chen Y-T, Kishnani PS, Koeberl D (2013) Glycogen storage diseases. In: Beaudet AL, Vogelstein B, Kinzler KW et al (eds) The online metabolic and molecular bases of inherited disease New York. The McGraw-Hill Companies, Inc., NY
go back to reference Correia CE, Bhattacharya K, Lee PJ et al (2008) Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am J Clin Nutr 88:1272–1276PubMedCentralPubMed Correia CE, Bhattacharya K, Lee PJ et al (2008) Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am J Clin Nutr 88:1272–1276PubMedCentralPubMed
go back to reference Fardet A, Abecassis J, Hoebler C et al (1999) Influence of technological modifications of the protein network from pasta on in vitro starch degradation. J Cereal Sci 30:133–145CrossRef Fardet A, Abecassis J, Hoebler C et al (1999) Influence of technological modifications of the protein network from pasta on in vitro starch degradation. J Cereal Sci 30:133–145CrossRef
go back to reference Kasapkara CS, Cinasal Demir G, Hasanoglu A, Tumer L (2014) Continuous glucose monitoring in children with glycogen storage disease type I. Eur J Clin Nutr 68:101–105CrossRefPubMed Kasapkara CS, Cinasal Demir G, Hasanoglu A, Tumer L (2014) Continuous glucose monitoring in children with glycogen storage disease type I. Eur J Clin Nutr 68:101–105CrossRefPubMed
go back to reference Kishnani PS, Austin SL, Abdenur JE et al (2014) Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med : Off J Am Coll Med Genet 16, e1 Kishnani PS, Austin SL, Abdenur JE et al (2014) Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med : Off J Am Coll Med Genet 16, e1
go back to reference Rake JP, Visser G, Labrune P et al (2002) Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161(Suppl 1):S112–S119CrossRefPubMed Rake JP, Visser G, Labrune P et al (2002) Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161(Suppl 1):S112–S119CrossRefPubMed
go back to reference Riva M, Fessas D, Schiraldi A (2000) Starch retrogradation in cooked pasta and rice. Cereal Chem 77:433–438CrossRef Riva M, Fessas D, Schiraldi A (2000) Starch retrogradation in cooked pasta and rice. Cereal Chem 77:433–438CrossRef
go back to reference Senn S (2002) Crossover trials in clinical research. Wiley Publishing, ChichesterCrossRef Senn S (2002) Crossover trials in clinical research. Wiley Publishing, ChichesterCrossRef
go back to reference Shah KK, O'Dell SD (2013) Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis. J Hum Nutr Diet : Off J Br Diet Assoc 26:329–339CrossRef Shah KK, O'Dell SD (2013) Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis. J Hum Nutr Diet : Off J Br Diet Assoc 26:329–339CrossRef
go back to reference Weinstein DA, Wolfsdorf JI (2002) Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr 161(Suppl 1):S35–S39CrossRefPubMed Weinstein DA, Wolfsdorf JI (2002) Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr 161(Suppl 1):S35–S39CrossRefPubMed
go back to reference White FJ, Jones SA (2011) The use of continuous glucose monitoring in the practical management of glycogen storage disorders. J Inherit Metab Dis 34:631–642CrossRefPubMed White FJ, Jones SA (2011) The use of continuous glucose monitoring in the practical management of glycogen storage disorders. J Inherit Metab Dis 34:631–642CrossRefPubMed
go back to reference Wiesli P, Brandle M, Schwegler B, Lehmann R, Spinas GA, Schmid C (2002) A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast. J Intern Med 252:504–509CrossRefPubMed Wiesli P, Brandle M, Schwegler B, Lehmann R, Spinas GA, Schmid C (2002) A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast. J Intern Med 252:504–509CrossRefPubMed
go back to reference Wolever TM, Jenkins DJ, Kalmusky J et al (1986) Glycemic response to pasta: effect of surface area, degree of cooking, and protein enrichment. Diabetes Care 9:401–404CrossRefPubMed Wolever TM, Jenkins DJ, Kalmusky J et al (1986) Glycemic response to pasta: effect of surface area, degree of cooking, and protein enrichment. Diabetes Care 9:401–404CrossRefPubMed
go back to reference Wolfsdorf JI, Crigler JF Jr (1997) Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease. Am J Clin Nutr 65:1507–1511PubMed Wolfsdorf JI, Crigler JF Jr (1997) Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease. Am J Clin Nutr 65:1507–1511PubMed
Metadata
Title
Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study
Authors
Michel Hochuli
Emanuel Christ
Fabian Meienberg
Roger Lehmann
Jan Krützfeldt
Matthias R. Baumgartner
Publication date
01-11-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-015-9864-2

Other articles of this Issue 6/2015

Journal of Inherited Metabolic Disease 6/2015 Go to the issue